Here are relevant reports on : vehicle-dynamics-testing-market
-
Internet of Things (IoT) Testing Market by Testing Type (Functional, Performance, Network, Security, Compatibility, and Usability), Service Type (Professional and Managed), Application Type, and Region - Global Forecast to 2021
The IoT testing market size is estimated to grow from USD 302.9 Million in 2016 to USD 1,378.5 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 35.4%. The major forces driving the IoT testing market include the growing need for Internet Protocol (IP) testing of the increasing number of IoT devices and applications. Moreover, the need for shift left testing of IoT applications and the rising importance of DevOps are also some of the factors which are driving the market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030
The global lateral flow assay components market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is projected to advance at a resilient CAGR of 4.4% from 2025 to 2030, culminating in a forecasted valuation of US$486.2 million by the end of the period. Market growth is driven by increasing health awareness and the shift toward lifestyle and home-based healthcare, as more consumers adopt self-monitoring and rapid testing solutions.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Testing, Inspection, and Certification (TIC) Market by Service Type (Testing, Inspection, Certification), Source (In-house, Outsourced), Application (Consumer Goods & Retail, Agriculture & Food, Chemical, Energy & Power) - Global Forecast to 2030
The global testing, inspection, and certification (TIC) market is expected to grow from USD 239.48 billion in 2025 to USD 282.76 billion by 2030, at a compound annual growth rate (CAGR) of 3.4% during the forecast period. The Key Players SGS SA (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), TÜV SÜD (Germany), and TÜV Rheinland (Germany).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Hematology Testing Market byTest [CBC (Hemoglobin, Hematocrit, & RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, & DPG], End User (& Clinical Testing Labs, Research Institute, & Hospital) - Global Forecasts to 2019
Emerging markets such as China, India, Brazil, and Mexico are the new revenue pockets for companies that are engaged in the development and marketing of hematology analyzers and reagents. Growing patient population, rising healthcare expenditure, and rising trends of medical tourism owing to low-cost treatments are the key factors propelling demand for hematology tests in these emerging nations.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Agricultural Testing Market by Sample (Soil, Water, Seed, Compost, Manure, Biosolids, Plant Tissue), Application (Saftey Testing, Quality Assurance), Technology (Conventional, Rapid) and Region ( North America, Europe, APAC, Row) - Global Forecast to 2028
According to MarketsandMarkets, the agricultural testing market is projected to reach USD 9.8 billion by 2028, at a CAGR of 7.1% during the forecast period. This report includes a study of the marketing and development strategies, along with the product portfolio of leading companies. These companies include SGS (Switzerland), Eurofins (Luxembourg), Intertek (UK), Bureau Veritas (France), ALS Limited (Australia), TUV Nord Group (Germany), Merieux (US), AsureQuality (New Zealand), RJ Hill Laboratories Limited (New Zealand), SCS Global (US), Agrifood Technology (Australia), APAL Agricultural Laboratory (Australia), Agvise Laboratories (US), LGC Limited (UK) and Water Agricultural Laboratories (US)
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Zika Virus Testing Market by Technology, (Molecular Test (Polymerase Chain Reaction, Nucleic Acid Amplification Testing), Serology Test (Elisa, Prnt), End User (Diagnostic Laboratory, Hospital, Clinics, Academic Institutes) - Global Forecast to 2023
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
EV Battery Testing Market by Testing Type (Safety, Performance), Battery Technology (Conventional Batteries, CTP, CTC), Form Factor (Cylindrical, Prismatic, Pouch), Sourcing Type, Chemistry, Propulsion, EV Type, and Region - Global Forecast to 2030
The EV battery testing market is projected to reach USD 9.51 billion in 2030 at a CAGR of 19.0% during the forecast period. The EV battery testing market is dominated by global players such as TÜV SÜD (Germany), Intertek Group plc (UK), UL LLC (US), Bureau Veritas (Belgium) and SGS Société Générale de Surveillance SA (Switzerland). These companies adopted new service launches, partnerships, collaboration, and other strategies to gain traction in the rolling stock market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
The global legionella testing market growth is primed to transition from $296.0 million in 2022 to $439.0 million by 2027, showcasing a strong CAGR of 8.2%. The rising geriatric population, combined with the rising prevalence of legionella-related illness and rising demand for rapid diagnostics, is driving growth in this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
